Table 4.
Risk of bias of the included in vivo studies.
Study | A | B | C | D | E | F | G | H | I | J | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Jiang et al., 1982 | √ | √ | √ | 3 | |||||||
Tang et al., 1989 | √ | √ | √ | 3 | |||||||
Li et al., 1996 | √ | √ | √ | 3 | |||||||
Zhang et al., 2010 | √ | √ | √ | √ | √ | 5 | |||||
Lu et al., 2010 | √ | √ | √ | 3 | |||||||
Li et al., 2012 | √ | √ | √ | √ | √ | √ | 6 | ||||
Yin et al., 2013 | √ | √ | √ | √ | √ | √ | 6 | ||||
Yu J. et al., 2015 | √ | √ | √ | √ | √ | √ | 6 | ||||
Wei et al., 2016 | √ | √ | √ | √ | 4 | ||||||
Song et al., 2016 | √ | √ | √ | √ | √ | √ | 6 | ||||
Fan et al., 2016 | √ | √ | √ | √ | √ | √ | 6 | ||||
Li et al., 2016 | √ | √ | √ | √ | √ | √ | 6 | ||||
Hu et al., 2016 | √ | √ | √ | √ | √ | √ | 6 | ||||
Yin et al., 2017 | √ | √ | √ | √ | √ | √ | √ | 7 | |||
Gao et al., 2017 | √ | √ | √ | √ | √ | √ | 6 | ||||
Dong et al., 2009 | √ | √ | √ | √ | √ | 5 | |||||
Xiang et al., 2009 | √ | √ | √ | √ | 4 | ||||||
Cheng et al., 2010 | √ | √ | √ | √ | 4 | ||||||
Zhao et al., 2012 | √ | √ | √ | √ | 4 | ||||||
Quan et al., 2012 | √ | √ | √ | √ | 4 | ||||||
Cui G. et al., 2013 | √ | √ | √ | √ | √ | √ | 6 | ||||
Chen et al., 2014 | √ | √ | √ | √ | 4 | ||||||
Cui et al., 2014 | √ | √ | √ | √ | √ | 5 | |||||
Wang et al., 2016 | √ | √ | √ | √ | √ | 5 | |||||
Zhang X. et al., 2017 | √ | √ | √ | √ | 4 | ||||||
Wang et al., 2017 | √ | √ | √ | √ | √ | √ | 6 | ||||
Tang et al., 2018 | √ | √ | √ | √ | √ | 5 |
Studies fulfilling the criteria of: A, peer reviewed publication; B, control of temperature; C, random allocation to treatment or control; D, blinded induction of model; E, blinded assessment of outcome; F, use of anesthetic without significant intrinsic vascular protection activity; G, appropriate animal model (aged, diabetic, or hypertensive); H, sample size calculation; I, compliance with animal welfare regulations; J, statement of potential conflict of interests.